Iovance Biotherapeutics
28 open jobs
Associate Director, Regulatory Affairs
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Associate Director, Regulatory Affairs at Iovance Biotherapeutics seen live 1 day ago posted 5 days agoInstrumentation & Equipment Specialist II (3rd Shift Sunday - Wednesday, 10:00pm - 8:30am)
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Instrumentation & Equipment Specialist II (3rd Shift Sunday - Wednesday, 10:00pm - 8:30am) at Iovance Biotherapeutics seen live 1 day ago posted 11 days agoAseptic Manufacturing Technician I - Night Shift A [Contract to Hire]
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Aseptic Manufacturing Technician I - Night Shift A [Contract to Hire] at Iovance Biotherapeutics seen live 1 day ago posted 12 days agoSenior Manager, Supply Planning
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Senior Manager, Supply Planning at Iovance Biotherapeutics seen live 1 day ago posted 13 days agoAseptic Manufacturing Technician I - Night Shift A [Contract to Hire]
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Aseptic Manufacturing Technician I - Night Shift A [Contract to Hire] at Iovance Biotherapeutics seen live 1 day ago posted 14 days agoDirector, Clinical Operations
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Director, Clinical Operations at Iovance Biotherapeutics seen live 1 day ago posted 19 days agoClinical QA Specialist II, Clinical Specialist Providers (CSP)
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Clinical QA Specialist II, Clinical Specialist Providers (CSP) at Iovance Biotherapeutics seen live 1 day ago posted 20 days agoCell Therapy Account Management - North Texas
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Cell Therapy Account Management - North Texas at Iovance Biotherapeutics seen live 1 day ago posted 21 days agoAseptic Manufacturing Technician I - Night Shift B [Contract to Hire]
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Aseptic Manufacturing Technician I - Night Shift B [Contract to Hire] at Iovance Biotherapeutics seen live 1 day ago posted 26 days agoAseptic Manufacturing Technician I - Day Shift A [Contract to Hire]
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Aseptic Manufacturing Technician I - Day Shift A [Contract to Hire] at Iovance Biotherapeutics seen live 1 day ago posted 26 days agoProduction Planner
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Lead Endpoint Engineering Architect
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Lead Endpoint Engineering Architect at Iovance Biotherapeutics seen live 1 day ago posted 32 days agoAssociate Director, Digital Experience & AI Production
Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system
Applyto Associate Director, Digital Experience & AI Production at Iovance Biotherapeutics seen live 1 day ago posted 33 days agoIT Support Analyst II
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Aseptic Manufacturing Technician I - Night Shift B [Contract to Hire]
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Aseptic Manufacturing Technician I - Night Shift B [Contract to Hire] at Iovance Biotherapeutics seen live 1 day ago posted 38 days agoSenior Project Manager
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Director, US Scientific Marketing – Melanoma
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Director, US Scientific Marketing – Melanoma at Iovance Biotherapeutics seen live 1 day ago posted 46 days agoSenior Manager, Cost Accounting
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Senior Manager, Cost Accounting at Iovance Biotherapeutics seen live 1 day ago posted 46 days agoMaster Scheduler
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Senior Manager, Biostatistics
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Senior Manager, Biostatistics at Iovance Biotherapeutics seen live 1 day ago posted 73 days agoSupervisor, Engineering & Maintenance (Monday - Friday; 3:00pm - 11:30pm)
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Supervisor, Engineering & Maintenance (Monday - Friday; 3:00pm - 11:30pm) at Iovance Biotherapeutics seen live 1 day ago posted 74 days agoManager, Investor Relations and Corporate Communications
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Manager, Investor Relations and Corporate Communications at Iovance Biotherapeutics seen live 1 day ago posted 75 days agoAseptic Manufacturing Technician I- Night Shift B [Contract to Hire]
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Aseptic Manufacturing Technician I- Night Shift B [Contract to Hire] at Iovance Biotherapeutics seen live 1 day ago posted 83 days agoManager, Regulatory Affairs
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Manager, Regulatory Affairs at Iovance Biotherapeutics seen live 1 day ago posted 102 days agoVice President, US Field Medical Affairs
Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system
Applyto Vice President, US Field Medical Affairs at Iovance Biotherapeutics seen live 1 day ago posted 105 days agoRegulatory Affairs CMC Associate II
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Regulatory Affairs CMC Associate II at Iovance Biotherapeutics seen live 1 day ago posted 125 days agoPrincipal AI Systems Engineer
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Principal AI Systems Engineer at Iovance Biotherapeutics seen live 1 day ago posted 127 days agoExecutive Director, Lifecycle Leader
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time
Applyto Executive Director, Lifecycle Leader at Iovance Biotherapeutics seen live 1 day ago posted 187 days ago